[Cardiovascular disease and risk factors in candidates for renal transplantation]

Luís Henrique Wolff Gowdak1, Flávio Jota de Paula, Dante Marcelo Artigas Giorgi

  • 1Incor, Hospital das Clínicas, FMUSP, São Paulo, SP. luis.gowdak@incor.usp.br

Insights

Cardiovascular disease (CVD) and risk factors are common in chronic renal failure patients awaiting kidney transplants. Standard risk scores underestimate their actual CVD risk, highlighting the need for tailored assessments.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Context:

  • Chronic renal failure (CRF) patients undergoing evaluation for kidney transplantation represent a unique population with high cardiovascular disease (CVD) risk.
  • Assessing CVD prevalence and traditional risk factors is crucial for managing these patients pre-transplant.

Purpose:

  • To determine the prevalence of cardiovascular disease (CVD) and traditional risk factors in patients with chronic renal failure (CRF) awaiting kidney transplantation.
  • To evaluate the adequacy of Framingham risk equations in this specific patient cohort.

Summary:

  • A study of 195 CRF patients found 37% had pre-existing CVD, with peripheral vascular disease most common.
  • CRF patients exhibited higher rates of male sex, diabetes, and smoking, along with greater left ventricular hypertrophy compared to controls.
  • Relative risk for CVD in CRF patients was elevated compared to Framingham controls but similar to hypertensive individuals.

Impact:

  • Findings indicate a high burden of CVD and risk factors in kidney transplant candidates.
  • The Framingham risk equations appear insufficient for accurately quantifying cardiovascular risk in CRF patients.
  • Additional, population-specific risk factors likely contribute to the elevated CVD risk in this group, necessitating further investigation and tailored risk management strategies.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...